furosemide doses were associated with worse survival, identifying worse cases or suggesting a detrimental effect of over-diuresis. Lower blood pressure was also associated with decreased survival, probably because of lower cardiac output and worse cardiac disease. The relationship between heart failure, renal function and diuresis should be explored prospectively in larger study populations.
METHODS
Data were obtained from 426 dogs enrolled in a longitudinal study from first opinion practices based in London between 2004 and 2017. PCV was compared between dogs at different American College of Veterinary Internal Medicine (ACVIM) stages of disease and factors related to changes in PCV were evaluated including; age, sex, breed, total protein, blood urea nitrogen, the left atrial to aortic root ratio and the normalised left ventricular internal diameter (LVIDDN).
RESULTS
One-way ANOVA showed a significant difference (p < 0.001) between all four ACVIM stages. Dogs in stage B2 (41.12 ± 6.15, p < 0.001) had a significantly lower PCV than all other stages (A: 46.14 ± 4.97, p < 0.001, B1: 43.44 ± 5.80, p = 0.012, C: 43.98 ±4.57, p = 0.048). The results additionally demonstrated that the mean PCV of dogs in stage A was the greatest and differed significantly from both stage B1 (p = 0.007) and B2 (p < 0.001).
A multivariable linear regression analysis revealed that patient age (-0.154 ± 0.111, p = 0.006), ACVIM stage (-0.122 ± 0.496, p = 0.40), LVIDDN (-0.160 ± 1.122, p = 0.008) and breed (0.471 ± 0.661, p = 0.001) all had a significant and independent effect on PCV.
STATEMENT (CONCLUSIONS)
There is a link between mitral valve disease and red blood cell count in dogs, which differs from human disease. A decrease in red blood cell count is seen with diseased progression until patients enter congestive heart failure when there is an increase. 
METHODS
Retrospective description of six dogs with pulmonic stenosis undergoing a transvascular pulmonic stent procedure in two cardiology referral centres, describing the approach and short-term outcomes.
RESULTS
Six dogs underwent a pulmonic stent procedure over a 12-month period. All dogs were diagnosed with severe, type B pulmonic stenosis based on echocardiographic criteria. Five French Bulldogs and one English Bulldog were treated. Two patients presented with signs of right sided congestive heart failure, two with erythrocytosis (concurrent right-to-left intracardiac shunts), one with syncope and one with marked exercise intolerance/ lethargy. Five dogs successfully received balloonexpandable metallic stents via a venous approach. In one dog, the stent could not be positioned appropriately and a hybrid procedure was successfully performed to place the stent retrograde, via the left pulmonary artery. No major complications were reported, although all dogs experienced reduced cardiac output and arrhythmias during stent deployment. All dogs experienced an improvement in clinical signs at one month post-operatively.
